Literature DB >> 9093015

Lipopolysaccharide induced acute red eye and corneal ulcers.

C L Schultz1, D W Morck, S G McKay, M E Olson, A Buret.   

Abstract

Using a new animal model, the aims of this study were to assess the role played by purified lipopolysaccharide (LPS) and neutrophils in the pathogenesis of acute red-eye reactions (ARE) and corneal ulcers. In addition, IL-1 alpha was assessed for its implications in the formation of corneal ulcers. Following corneal abrasion, eyes of rabbits underwent single or double exposures to various doses of LPS from Pseudomonas aeruginosa or Serratia marcescens. This protocol induced ARE symptoms, and their severity depended on the dosage, number of LPS exposures, and type of LPS used (LPS from S. marcescens showing highest virulence). Corneal ulcers were induced by delivering a high dose of Serratia LPS (100 micrograms) followed by a low dose (10 micrograms). Histopathological examination revealed that both ARE and corneal ulceration were associated with prominent neutrophil infiltration. In addition, many lymphocytes and other monocytic cells infiltrated ulcerated ocular tissue. Tear fluids obtained from ulcerated eyes contained high concentrations of a protein recognized by anti-rabbit IL-1 alpha antibodies as demonstrated by immunoblotting studies. The results indicate that LPS can induce ARE and corneal ulceration in the absence of any live bacteria. Moreover, the findings implicate the accumulation of neutrophils and IL-1 alpha-related proteins in the pathogenesis of ARE and corneal ulcers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9093015     DOI: 10.1006/exer.1996.0190

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  18 in total

1.  Overexpression of IL-8 in the cornea induces ulcer formation in the SCID mouse.

Authors:  M Oka; K Norose; K Matsushima; C Nishigori; M Herlyn
Journal:  Br J Ophthalmol       Date:  2006-01-17       Impact factor: 4.638

2.  The role of toll-like receptor 4 in corneal epithelial wound healing.

Authors:  Medi Eslani; Asadolah Movahedan; Neda Afsharkhamseh; Herve Sroussi; Ali R Djalilian
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-02       Impact factor: 4.799

3.  Lipopolysaccharide entry in the damaged cornea and specific uptake by polymorphonuclear neutrophils.

Authors:  C L Schultz; A G Buret; M E Olson; H Ceri; R R Read; D W Morck
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Innate immune regulation of Serratia marcescens-induced corneal inflammation and infection.

Authors:  Rong Zhou; Rui Zhang; Yan Sun; Sean Platt; Loretta Szczotka-Flynn; Eric Pearlman
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-25       Impact factor: 4.799

5.  Bone marrow chimeras and c-fms conditional ablation (Mafia) mice reveal an essential role for resident myeloid cells in lipopolysaccharide/TLR4-induced corneal inflammation.

Authors:  Holly R Chinnery; Eric C Carlson; Yan Sun; Michelle Lin; Sandra H Burnett; Victor L Perez; Paul G McMenamin; Eric Pearlman
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 6.  Toll-like receptors at the ocular surface.

Authors:  Eric Pearlman; Angela Johnson; Gautam Adhikary; Yan Sun; Holly R Chinnery; Todd Fox; Mark Kester; Paul G McMenamin
Journal:  Ocul Surf       Date:  2008-07       Impact factor: 5.033

7.  Mucin degradation mechanisms by distinct Pseudomonas aeruginosa isolates in vitro.

Authors:  Lina Panayiota Aristoteli; Mark D P Willcox
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Ethyl pyruvate ameliorates endotoxin-induced corneal inflammation.

Authors:  Divya Gupta; Yiqin Du; Jordan Piluek; Adam M Jakub; Kristine Ann Buela; Akshar Abbott; Joel S Schuman; Nirmala SundarRaj
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-25       Impact factor: 4.799

9.  C-Jun NH2 terminal kinase (JNK) is an essential mediator of Toll-like receptor 2-induced corneal inflammation.

Authors:  Gautam Adhikary; Yan Sun; Eric Pearlman
Journal:  J Leukoc Biol       Date:  2008-01-24       Impact factor: 4.962

10.  Inhibition of corneal inflammation by the TLR4 antagonist Eritoran tetrasodium (E5564).

Authors:  Yan Sun; Eric Pearlman
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-20       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.